Commentary
Nature Biotechnology 26, 1077 - 1083 (2008)
doi:10.1038/nbt1008-1077
New therapies from old medicines
Shaw T Chen1, Jinhui Dou1, Robert Temple1, Rajiv Agarwal1, Kuei-Meng Wu1 & Susan Walker1
-
Shaw T. Chen is associate director & botanical team leader, Jinhui Dou is pharmacognosy reviewer, Robert Temple is director of the Office of Drug Evaluation, Rajiv Agarwal is chemistry reviewer, Kuei-Meng Wu is pharmacology reviewer and Susan Walker is director of the Division of Dermatological and Dental Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Building 22, Silver Spring, Maryland 20993-0002, USA.
e-mail: shaw.chen@fda.hhs.gov
Abstract
Although new botanical drugs pose many challenges for both industry and the FDA, approval of the first botanical prescription drug shows they can be successfully met.
